Australia's largest stock trading and investment forum Australia's #1 stock forum

NTI

Click for more information

1.89%

5.4¢ neurotech international limited

Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint, page-19

First 19 Last

Share
Profile

Follow
Tony barber

6,531 Posts.

720

03/05/24

12:29

Post #: 73649340
Share

Originally posted by ttppxx ↑

I disagree!

Check the timeline of other companies (such as NEU). The release of Topline results is not abnormal: it happens all the time. It is then followed by full results, which will include more details on not just the size of a treatment effect, but will have adverse effects as well as subgroup analyses, etc.

All of that is useful for shareholders, investors and traders, who use that to forecast, predict, and speculate. That
it works is not enough: the harms matter too.

These companies are under Continuous disclosure rules, so once they know of critically importan results which they know won't change much after further alnalyses, they have to announce them (even before the full results).

We know the headline results: it works! But we also need the details: how well does it work, at what health costs to the patient? We will use particularly those missing details to compare this treatment with that offered by others (sush as Daybue from NEU).

A Trading Halt provides us all with a relatively even playing field. News will always leak, so it's better to close us all out while at the stage that might affect results.

So, nothing amiss in my view.

Expand

You aren't going to know financial costs to patients !
Years away from knowing that.

NTI Price at posting: 9.1¢ Sentiment: Buy Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

What's causing the cost-of-living crisis, and how to navigate it

There are more pages in this discussion • 33 more messages in this thread...

First 19 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 5.4¢		Change 0.001(1.89%)		Mkt cap ! $55.86M

Open	High	Low	Value	Volume
5.4¢	5.5¢	5.4¢	$41.48K	762.7K

Buyers (Bids)

No.	Vol.	Price($)
3	478888	5.3¢

Sellers (Offers)

Price($)	Vol.	No.
5.4¢	40510	1

View Market Depth

No.	Vol.	Price($)
2	290000	0.053
1	20000	0.052
1	5000	0.051
3	1505000	0.050
3	240863	0.048

Price($)	Vol.	No.
0.054	40510	1
0.055	45160	1
0.056	63420	1
0.058	177059	2
0.059	128477	2

Last trade - 15.44pm 18/10/2024 (20 minute delay)

NTI (ASX) Chart